Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.

Cancer control : journal of the Moffitt Cancer Center - 1 Jan 2000

Feng Zhenxing, Yin Yan, Liu Bin, Zheng Yafang, Shi Dongsheng, Zhang Hong, Qin Jianwen

Abstract excerpt

BACKGROUND: The FAT atypical cadherin 1/2/3/4 (FAT1/2/3/4) has been linked to the occurrence and development of various cancers. However, the prognostic and immunological role of FAT1/2/3/4 in non-small cell lung cancer (NSCLC) has not been clarified. METHODS: The association of FAT1/2/3/4 mutations with tumor mutation burden (TMB), tumor immunity in the microenvironment, and response to ICIs in NSCLC was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to CD8-Positive T-Lymphocytes

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 35212236
DOI: 10.1177/10732748221076682
PMCID: PMC8891876

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.PMID 35212236Read ↗

Potential predictive value of comutant LRP1B and FAT for immune response in non-small cell lung cancerSemantic proximity Read ↗

Identification of FAT4 Mutation as a Prognostic Marker for Overall Survival and Immune Landscape in Lung AdenocarcinomaSemantic proximity Read ↗

Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy.Semantic proximity Read ↗

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.Semantic proximity Read ↗

Distinct Expression Pattern and Prognostic Values of E2F Family Genes in Lung Adenocarcinoma and Squamous Cell CarcinomaSemantic proximity Read ↗

Tumor-suppressor signature for robust prognosis and prediction in adenocarcinoma non–small cell lung cancerSemantic proximity Read ↗

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.Semantic proximity Read ↗

Four and a half LIM domain protein 1 as a Novel Prognostic Biomarker and Correlation with Immune Infiltration Levels in Lung AdenocarcinomaSemantic proximity Read ↗

A pan-cancer analysis of the FAT1 in human tumors.Semantic proximity Read ↗

Identification of differentially expressed genes in non-small cell lung cancerSemantic proximity Read ↗

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.Semantic proximity Read ↗

A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.